Literature DB >> 22057273

Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent.

Katrin Isfort1, Franziska Ebert, Julia Bornhorst, Sarah Sargin, Rozina Kardakaris, Manolis Pasparakis, Martin Bähler, Tanja Schwerdtle, Albrecht Schwab, Peter J Hanley.   

Abstract

Adenosine 5'-triphosphate (ATP) has been implicated in the recruitment of professional phagocytes (neutrophils and macrophages) to sites of infection and tissue injury in two distinct ways. First, ATP itself is thought to be a chemotactic "find me" signal released by dying cells, and second, autocrine ATP signaling is implicated as an amplifier mechanism for chemotactic navigation to end-target chemoattractants, such as complement C5a. Here we show using real-time chemotaxis assays that mouse peritoneal macrophages do not directionally migrate to stable analogs of ATP (adenosine-5'-(γ-thio)-triphosphate (ATPγS)) or its hydrolysis product ADP (adenosine-5'-(β-thio)-diphosphate (ADPβS)). HPLC revealed that these synthetic P2Y(2) (ATPγS) and P2Y(12) (ADPβS) receptor ligands were in fact slowly degraded. We also found that ATPγS, but not ADPβS, promoted chemokinesis (increased random migration). Furthermore, we found that photorelease of ATP or ADP induced lamellipodial membrane extensions. At the cell signaling level, C5a, but not ATPγS, activated Akt, whereas both ligands induced p38 MAPK activation. p38 MAPK and Akt activation are strongly implicated in neutrophil chemotaxis. However, we found that inhibitors of phosphatidylinositol 3-kinase (PI3K; upstream of Akt) and p38 MAPK (or conditional deletion of p38α MAPK) did not impair macrophage chemotactic efficiency or migration velocity. Our results suggest that PI3K and p38 MAPK are redundant for macrophage chemotaxis and that purinergic P2Y(2) and P2Y(12) receptor ligands are not chemotactic. We propose that ATP signaling is strictly autocrine or paracrine and that ATP and ADP may act as short-range "touch me" (rather than long-range find me) signals to promote phagocytic clearance via cell spreading.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057273      PMCID: PMC3247992          DOI: 10.1074/jbc.M111.289793

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Inflammation bares a dark side.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

2.  ATP mediates rapid microglial response to local brain injury in vivo.

Authors:  Dimitrios Davalos; Jaime Grutzendler; Guang Yang; Jiyun V Kim; Yi Zuo; Steffen Jung; Dan R Littman; Michael L Dustin; Wen-Biao Gan
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

3.  ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

Authors:  Yu Chen; Ross Corriden; Yoshiaki Inoue; Linda Yip; Naoyuki Hashiguchi; Annelies Zinkernagel; Victor Nizet; Paul A Insel; Wolfgang G Junger
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

4.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

Authors:  C J Foster; D M Prosser; J M Agans; Y Zhai; M D Smith; J E Lachowicz; F L Zhang; E Gustafson; F J Monsma; M T Wiekowski; S J Abbondanzo; D N Cook; M L Bayne; S A Lira; M S Chintala
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility.

Authors:  Peter J Hanley; Yan Xu; Moritz Kronlage; Kay Grobe; Peter Schön; Jian Song; Lydia Sorokin; Albrecht Schwab; Martin Bähler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 6.  Immune cell regulation by autocrine purinergic signalling.

Authors:  Wolfgang G Junger
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

7.  Autocrine purinergic receptor signaling is essential for macrophage chemotaxis.

Authors:  Moritz Kronlage; Jian Song; Lydia Sorokin; Katrin Isfort; Tanja Schwerdtle; Jens Leipziger; Bernard Robaye; Pamela B Conley; Hee-Cheol Kim; Sarah Sargin; Peter Schön; Albrecht Schwab; Peter J Hanley
Journal:  Sci Signal       Date:  2010-07-27       Impact factor: 8.192

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance.

Authors:  Michael R Elliott; Faraaz B Chekeni; Paul C Trampont; Eduardo R Lazarowski; Alexandra Kadl; Scott F Walk; Daeho Park; Robin I Woodson; Marina Ostankovich; Poonam Sharma; Jeffrey J Lysiak; T Kendall Harden; Norbert Leitinger; Kodi S Ravichandran
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

10.  ATP release from non-excitable cells.

Authors:  Helle A Praetorius; Jens Leipziger
Journal:  Purinergic Signal       Date:  2009-03-20       Impact factor: 3.765

View more
  23 in total

Review 1.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

Review 2.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

3.  A novel isoform of myosin 18A (Myo18Aγ) is an essential sarcomeric protein in mouse heart.

Authors:  Markus Horsthemke; Lauryl M J Nutter; Anne C Bachg; Boris V Skryabin; Ulrike Honnert; Thomas Zobel; Sven Bogdan; Monika Stoll; Matthias D Seidl; Frank U Müller; Ursula Ravens; Andreas Unger; Wolfgang A Linke; Pim R R van Gorp; Antoine A F de Vries; Martin Bähler; Peter J Hanley
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

Review 4.  Receptors, ion channels, and signaling mechanisms underlying microglial dynamics.

Authors:  Christian Madry; David Attwell
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

5.  RhoJ integrates attractive and repulsive cues in directional migration of endothelial cells.

Authors:  Yoko Fukushima; Koichi Nishiyama; Hiroshi Kataoka; Marcus Fruttiger; Shigetomo Fukuhara; Kohji Nishida; Naoki Mochizuki; Hiroki Kurihara; Shin-Ichi Nishikawa; Akiyoshi Uemura
Journal:  EMBO J       Date:  2020-04-29       Impact factor: 11.598

6.  Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.

Authors:  Emilie Seydoux; Hong Liang; Natasha Dubois Cauwelaert; Michelle Archer; Nicholas D Rintala; Ryan Kramer; Darrick Carter; Christopher B Fox; Mark T Orr
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

7.  The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury.

Authors:  Adam D Bachstetter; Rachel K Rowe; Machi Kaneko; Danielle Goulding; Jonathan Lifshitz; Linda J Van Eldik
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

8.  Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis.

Authors:  Esther van den Bos; Benjamin Ambrosy; Markus Horsthemke; Stefan Walbaum; Anne C Bachg; Nina Wettschureck; Giulio Innamorati; Thomas M Wilkie; Peter J Hanley
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

Review 9.  The role of pannexin1 in the induction and resolution of inflammation.

Authors:  Samantha E Adamson; Norbert Leitinger
Journal:  FEBS Lett       Date:  2014-03-15       Impact factor: 4.124

10.  P38 and JNK have opposing effects on persistence of in vivo leukocyte migration in zebrafish.

Authors:  Harriet B Taylor; Juliane Liepe; Charlotte Barthen; Laurence Bugeon; Maxime Huvet; Paul D W Kirk; Simon B Brown; Jonathan R Lamb; Michael P H Stumpf; Margaret J Dallman
Journal:  Immunol Cell Biol       Date:  2012-11-20       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.